Search Within

Susan E Prockop

  1. "Guenther Koehne"
Formats
  1. Meeting Abstract (25)
  2. Journal Article (10)
  3. Conference Paper (1)
Groups
  1. Department of Medicine (36)
  2. Hematologic Malignancies, Division of (36)
  3. Pediatrics, Department of (36)
  4. Stem Cell Transplantation and Cellular Therapy Service (36)
  5. GSK Faculty (35)
  6. Immunology Program Faculty (35)

More Groups

People
  1. Guenther Koehne (36)
  2. Richard O'Reilly (35)
  3. Nancy Kernan (26)
  4. Esperanza Papadopoulos (24)
  5. Juliet Barker (23)
  6. Farid Boulad (21)

More People

Years
  1. 2020 (2)
  2. 2017 (5)
  3. 2016 (2)
  4. 2015 (4)
  5. 2014 (3)
  6. 2013 (5)

More Years

Publications
  1. Blood (16)
  2. Biology of Blood and Marrow Transplantation (13)
  3. Bone Marrow Transplantation (5)
  4. Best Practice and Research: Clinical Haematology (1)
  5. Journal of Pediatric Hematology/Oncology (1)
Publishers
  1. American Society of Hematology (16)
  2. Elsevier Inc. (14)
  3. Nature Publishing Group (5)
  4. Lippincott Williams & Wilkins (1)

Results (36)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Host T-cells contribute to immune reconstitution and improved outcome in recipients of CD34 selected T-cell depleted allografts (TCD HCT) with full hematopoietic cell but persistent mixed T-cell chimerism
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Heller, G.; Boulad, F.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Adoptive T-cell therapy with 3rd party CMV-pp65-specific CTLs for CMV viremia and disease arising after allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Rodriguez-Sanchez, I.; Hasan, A. N.; Barker, J.; Castro-Malaspina, H. R.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; Kernan, N. A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Radiation-free cytoreductive regimens and T-cell depleted allogeneic stem cell transplants (HSCT) for the treatment of 65 pediatric patients with hematologic malignancies
    Meeting Abstract

    Boulad, F.; Kernan, N. A.; Prockop, S. E.; Kobos, R.; Judge, A.; Cancio, M.; Curran, K. J.; Jackson, C. C.; Spitzer, B.; Koehne, G.; more...
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Five years of therapy with donor and 3rd party derived EBV and CMV specific cytotoxic T cells - Safety after more than 1,000 infusions
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Hasan, A.; Koehne, G.; Dahi, P.; Papadopoulos, E.; Sauter, C.; Rodriguez-Sanchez, I.; Suser, S.; Escobedo, V.; more...
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • A chemotherapy-only regimen of busulfan, melphalan, and fludarabine, and rabbit antithymocyte globulin followed by allogeneic T-cell depleted hematopoietic stem cell transplantations for the treatment of myeloid malignancies
    Journal Article

    Spitzer, B.; Jakubowski, A. A.; Papadopoulos, E. B.; Fuller, K.; Hilden, P. D.; Young, J. W.; Barker, J. N.; Koehne, G.; Perales, M. A.; Hsu, K. C.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Ex vivo CD34(+)–selected T cell–depleted peripheral blood stem cell grafts for allogeneic hematopoietic stem cell transplantation in acute leukemia and myelodysplastic syndrome is associated with low incidence of acute and chronic graft-versus-host disease and high treatment response
    Journal Article

    Barba, P.; Hilden, P.; Devlin, S. M.; Maloy, M.; Dierov, D.; Nieves, J.; Garrett, M. D.; Sogani, J.; Cho, C.; Barker, J. N.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Third party CMV-specific cytotoxic T cells for treatment of antiviral resistant CMV infection after hematopoietic stem cell transplant
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Hasan, A. N.; Dahi, P. B.; Giralt, S.; Koehne, G.; Kernan, N. A.; Papadopoulos, E. B.; Lehrman, R.; Rodriguez-Sanchez, I.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Virus-specific T-cell banks for 'off the shelf' adoptive therapy of refractory infections
    Journal Article

    O'Reilly, R. J.; Prockop, S.; Hasan, A. N.; Koehne, G.; Doubrovina, E.
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Successful treatment of refractory CMV chorioretinitis and meningoencephalitis with adoptive transfer of third party CMVpp65 specific T-cell Lines
    Meeting Abstract

    Prockop, S.; Hasan, A.; Doubrovina, E.; Castro-Malaspina, H. R.; Barker, J. N.; Dahi, P. B.; Boulad, F.; Kernan, N. A.; Koehne, G.; Sauter, C. S.; more...
    Blood (2015)

    Fulltext@MSK | Save